QIAGEN Supports Cervical Cancer Screening for Underprivileged Chinese Women
News Mar 06, 2009
To mark International Women’s Day on March 8th, QIAGEN provides human papillomavirus (HPV) testing products for the testing of underprivileged women at 29 hospitals across China.
The free testing program is part of the larger “3.8 Program” – a nationwide prevention campaign organized by the Cancer Foundation of China and partially sponsored by QIAGEN. HPV is the primary cause of cervical cancer.
“QIAGEN is proud to continue its partnership with the Cancer Foundation of China after the success of last year’s event,” said Dr. Victor Shi, Asia Area President of QIAGEN. “We must continue to increase awareness and work to make testing more widespread. If we are successful at this, cervical cancer can and will become a disease of the past.”
For the second year in a row, QIAGEN will provide HPV testing kits to the 29 hospitals taking part in the cervical cancer screening aspect of the event. These kits will be used in the screening of several thousand underprivileged women throughout China.
According to the Cancer Foundation of China, 17 of the hospitals involved in the 2008 cervical cancer screening activity reported their result, providing statistics for the testing of 1,617 women. Of those screened, 30 were found to have mild dysplasia (abnormal cell growth) due to HPV infection (CIN1), 5 had moderate dysplasia (CIN2), 4 had severe dysplasia (CIN3), and 5 were found to have invasive cervical cancer. All women found to have CIN2/3 and cancer were referred to local medical centers for further diagnosis and surgery if appropriate.
“Our goal at the Cancer Foundation of China is to improve awareness of cervical cancer and HPV screening in China to save lives,” said Prof. Qiao Youlin, General Director of the event and Chief of the Department of Cancer Epidemiology at the Cancer Institute, Chinese Academy of Medical Sciences. “Like QIAGEN, we believe that the best in preventative care, including HPV testing, should be available to all women. Last year we were able to help hundreds of women reduce their risk of developing cervical cancer.”
Retrained Enzyme is Biocatalysis MilestoneNews
TU Graz researchers managed for the first time ever to ‘retrain’ an enzyme to build ring-shaped molecular structures instead of performing its natural task of reducing double bonds. The work was published in Angewandte Chemie, and is relevant for the production of pharmaceuticals and plant protection products.
Laser Pulses and Fluorescence Enable Metabolite ViewingNews
In the search for new sources of drugs, biodegradables and biofuels scientists have come to realize that life itself could be the solution, using natural metabolites produced by bacteria to produce vital compounds like penicillin. Identifying which cells are most useful for this goal has proved a huge challenge, but a new system using fluorescence and lasers has enabled metabolite viewing in real time in algae cells.READ MORE
Comments | 0 ADD COMMENT
12th International Conference on Advancements in Bioinformatics and Drug Discovery
Nov 26 - Nov 27, 2018